These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26293520)

  • 21. Severe hypoglycaemia during treatment with sulphonylureas in patients with type 2 diabetes in the Capital Region of Denmark.
    Pilemann-Lyberg S; Thorsteinsson B; Snorgaard O; Zander M; Vestergaard H; Røder ME
    Diabetes Res Clin Pract; 2015 Nov; 110(2):202-7. PubMed ID: 26515912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of the association between the use of oral anti-hyperglycemic agents and hypoglycemia in Japan by data mining of the Japanese Adverse Drug Event Report (JADER) database].
    Umetsu R; Nishibata Y; Abe J; Suzuki Y; Hara H; Nagasawa H; Kinosada Y; Nakamura M
    Yakugaku Zasshi; 2014; 134(2):299-304. PubMed ID: 24492232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Sulfonylurea Use and Impaired Awareness of Hypoglycemia Among Patients With Type 2 Diabetes in Taiwan.
    Cheng HJ; Weng SH; Wu JL; Yeh ST; Chen HF; Novida H; Ou HT; Li CY
    Ann Fam Med; 2024 Jul; 22(4):309-316. PubMed ID: 38914437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac Effects of Sulfonylurea-Related Hypoglycemia.
    Middleton TL; Wong J; Molyneaux L; Brooks BA; Yue DK; Twigg SM; Wu T
    Diabetes Care; 2017 May; 40(5):663-670. PubMed ID: 28223296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Worry vs. knowledge about treatment-associated hypoglycaemia and weight gain in type 2 diabetic patients on metformin and/or sulphonylurea.
    Lund A; Knop FK
    Curr Med Res Opin; 2012 May; 28(5):731-6. PubMed ID: 22462528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of severe hypoglycemic events from amiodarone-sulfonylureas interactions: A population-based nested case-control study.
    Lai JH; Wang MT; Wu CC; Huang YL; Lu CH; Liou JT
    Pharmacoepidemiol Drug Saf; 2020 Aug; 29(8):842-853. PubMed ID: 32483856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and Tolerability of Linagliptin in Patients With Type 2 Diabetes: A Comprehensive Pooled Analysis of 22 Placebo-controlled Studies.
    Lehrke M; Marx N; Patel S; Seck T; Crowe S; Cheng K; von Eynatten M; Johansen OE
    Clin Ther; 2014 Aug; 36(8):1130-46. PubMed ID: 25015594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for adverse symptoms during dipeptidyl peptidase-IV inhibitor therapy: a questionnaire-based study carried out by the Japan Pharmaceutical Association Drug Event Monitoring project in Kumamoto Prefecture.
    Kajiwara A; Saruwatari J; Sakata M; Morita K; Kita A; Oniki K; Yamamura M; Murase M; Koda H; Hirota S; Ishizuka T; Nakagawa K
    Drug Saf; 2013 Oct; 36(10):981-7. PubMed ID: 23743694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenetics of hypoglycemia associated with sulfonylurea therapy in usual clinical care.
    Mitchell SL; Leon DAC; Chaugai S; Kawai VK; Levinson RT; Wei WQ; Stein CM
    Pharmacogenomics J; 2020 Dec; 20(6):831-839. PubMed ID: 32504053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CYP2C9*2 allele increases risk for hypoglycemia in POR*1/*1 type 2 diabetic patients treated with sulfonylureas.
    Ragia G; Tavridou A; Elens L; Van Schaik RH; Manolopoulos VG
    Exp Clin Endocrinol Diabetes; 2014 Jan; 122(1):60-3. PubMed ID: 24464600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe hypoglycemia in users of sulfonylurea antidiabetic agents and antihyperlipidemics.
    Leonard CE; Bilker WB; Brensinger CM; Han X; Flory JH; Flockhart DA; Gagne JJ; Cardillo S; Hennessy S
    Clin Pharmacol Ther; 2016 May; 99(5):538-47. PubMed ID: 26566262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroglycopenic Seizures: Sulfonylureas, Sulfamethoxazole, or Both?
    Khan U; Seetharaman S; Merchant R
    Am J Med; 2017 Jan; 130(1):e29-e30. PubMed ID: 27593606
    [No Abstract]   [Full Text] [Related]  

  • 33. Octreotide: an antidote for sulfonylurea-induced hypoglycemia.
    McLaughlin SA; Crandall CS; McKinney PE
    Ann Emerg Med; 2000 Aug; 36(2):133-138. PubMed ID: 10918104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presence of CYP2C9*3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas.
    Ragia G; Petridis I; Tavridou A; Christakidis D; Manolopoulos VG
    Pharmacogenomics; 2009 Nov; 10(11):1781-7. PubMed ID: 19891554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe hypoglycaemia the "tip of the iceberg": an underestimated risk in both type 1 and type 2 diabetic patients.
    Halimi S
    Diabetes Metab; 2015 Apr; 41(2):105-6. PubMed ID: 25824635
    [No Abstract]   [Full Text] [Related]  

  • 36. Inadvertent sulfonylurea overdosage and hypoglycemia in an elderly woman: failure of serum hypoglycemia screening.
    Earle KE; Rushakoff RJ; Goldfine ID
    Diabetes Technol Ther; 2003; 5(3):449-51. PubMed ID: 12828829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoglycemia in hospitalized patients treated with sulfonylureas.
    Deusenberry CM; Coley KC; Korytkowski MT; Donihi AC
    Pharmacotherapy; 2012 Jul; 32(7):613-7. PubMed ID: 22570146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying factors associated with hypoglycemia-related hospitalizations among elderly patients with T2DM in the US: a novel approach using influential variable analysis.
    Fu H; Xie W; Curtis B; Schuster D
    Curr Med Res Opin; 2014 Sep; 30(9):1787-93. PubMed ID: 24810150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ABCC8 polymorphism (Ser1369Ala): influence on severe hypoglycemia due to sulfonylureas.
    Sato R; Watanabe H; Genma R; Takeuchi M; Maekawa M; Nakamura H
    Pharmacogenomics; 2010 Dec; 11(12):1743-50. PubMed ID: 21142918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoglycemia in Frail Elderly Patients With Type 2 Diabetes Mellitus Treated With Sulfonylurea.
    van Dijk P; Bouma A; Landman GW; Groenier KH; Bilo H; Kleefstra N; van Hateren KJ
    J Diabetes Sci Technol; 2017 Mar; 11(2):438-439. PubMed ID: 27625346
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.